BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Cyclacel Pharmaceuticals Reports Fourth Quarter And Full Year 2022 Financial Results And Provides Business Update

  Cyclacel Pharmaceuticals, Inc. today announced fourth quarter and full year 2022 financial results and provided a business update.

  March 6, 2023

   · 

  9 min read
• Business

  MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue Results and Provides 2023 Revenue Guidance

  MaxCyte, Inc. today announced preliminary revenue results for the fourth quarter and full year 2022 and provided initial 2023 revenue guidance.

  March 6, 2023

   · 

  8 min read
• Deals

  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 6, 2023

  Apellis Pharmaceuticals , Inc. today announced that the company approved the grant of equity awards to 6 new employees with a grant date of March 1, 2023, as equity inducement awards outside of the company’s 2017 Stock Incentive Plan (but under the terms of the 2022 Inducement Stock Incentive Plan).

  March 6, 2023

   · 

  2 min read
• Business

  Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023

  Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December 31, 2022, after the market close on Monday, March 20, 2023.

  March 6, 2023

   · 

  1 min read
• Business

  Ocular Therapeutix™ Provides Fourth Quarter and Year-End 2022 Results and Corporate Update

  Ocular Therapeutix, Inc. today reported financial results for the fourth quarter and year ended December 31, 2022, and provided updates on its ophthalmology pipeline.

  March 6, 2023

   · 

  18 min read
• Business

  Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results

  Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its fourth quarter and full year ended December 31, 2022.

  March 6, 2023

   · 

  19 min read
• Business

  Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Thursday, March 9, 2023, at 8:00 a.m. ET

  Fulcrum Therapeutics, Inc. today announced that its fourth quarter and full year 2022 financial results will be released on Thursday, March 9, 2023 before the U.S. financial markets open.

  March 6, 2023

   · 

  1 min read
• Deals

  Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  Syndax Pharmaceuticals, Inc. today announced that on March 1, 2023 the Company granted an inducement award to purchase up to 15,200 shares of common stock to one new employee under the Company’s 2023 Inducement Plan.

  March 6, 2023

   · 

  1 min read
• Pharm Country

  Trevi Therapeutics to Participate in Upcoming March Conferences

  Trevi Therapeutics, Inc. today announced senior management will attend and participate in the following March conferences.

  March 6, 2023

   · 

  1 min read
• Deals

  Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - March 6, 2023

  Marinus Pharmaceuticals, Inc. today announced the grant of inducement awards to 1 new employee.

  March 6, 2023

   · 

  3 min read